LEPR and metabolic dysfunction-associated steatotic liver disease: Moreover, Slc39a5-/-; Lepr-/- mice displayed reduced NAFLD activity score (an aggregate score of macrovesicular steatosis, hepatocellular hypertrophy, and inflammation) (Figure 4E and Figure 4—figure supplement 1E).